Thromboxane b2

Thromboxane b2 is a lipid of Fatty Acyls (FA) class. Thromboxane b2 is associated with abnormalities such as endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia and Thrombocytosis. The involved functions are known as Platelet Activation, Excretory function, Anabolism, Inflammation and mRNA Expression. Thromboxane b2 often locates in Endothelium, Hepatic and Microsomes, Liver. The associated genes with Thromboxane b2 are PTGS2 gene, prothrombin fragment 2 and CCL14 wt Allele.

Cross Reference

Introduction

To understand associated biological information of Thromboxane b2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Thromboxane b2?

Thromboxane b2 is suspected in endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia, Thrombocytosis, Acute Coronary Syndrome and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Thromboxane b2

MeSH term MeSH ID Detail
Hemolysis D006461 131 associated lipids
Airway Obstruction D000402 13 associated lipids
Uremia D014511 33 associated lipids
Stomach Ulcer D013276 75 associated lipids
Kidney Failure, Chronic D007676 51 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Hypoxia D000860 23 associated lipids
Graft Occlusion, Vascular D006083 11 associated lipids
Arrhythmias, Cardiac D001145 42 associated lipids
Adenocarcinoma D000230 166 associated lipids
Ovarian Neoplasms D010051 10 associated lipids
Pain D010146 64 associated lipids
Contusions D003288 3 associated lipids
Autoimmune Diseases D001327 27 associated lipids
Lupus Erythematosus, Systemic D008180 43 associated lipids
Lung Diseases D008171 37 associated lipids
Lung Neoplasms D008175 171 associated lipids
Wounds and Injuries D014947 20 associated lipids
Pleurisy D010998 20 associated lipids
Burns D002056 34 associated lipids
Inflammation D007249 119 associated lipids
Reperfusion Injury D015427 65 associated lipids
Colitis D003092 69 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Diabetes Mellitus, Type 1 D003922 56 associated lipids
Diabetes Mellitus, Type 2 D003924 87 associated lipids
Diabetic Nephropathies D003928 39 associated lipids
Diabetic Retinopathy D003930 39 associated lipids
Cattle Diseases D002418 24 associated lipids
Fatty Liver D005234 48 associated lipids
Diabetes Mellitus, Experimental D003921 85 associated lipids
Mammary Neoplasms, Experimental D008325 67 associated lipids
Body Weight D001835 333 associated lipids
Edema D004487 152 associated lipids
Arthritis D001168 41 associated lipids
Arthritis, Experimental D001169 24 associated lipids
Hypotension D007022 41 associated lipids
Acute Kidney Injury D058186 34 associated lipids
Gastritis D005756 27 associated lipids
Heart Failure D006333 36 associated lipids
Pulmonary Edema D011654 23 associated lipids
Pulmonary Embolism D011655 5 associated lipids
Coronary Disease D003327 70 associated lipids
Liver Cirrhosis, Experimental D008106 36 associated lipids
Hypersensitivity D006967 22 associated lipids
Hypothyroidism D007037 32 associated lipids
Rhinitis D012220 10 associated lipids
Hypercapnia D006935 5 associated lipids
Arterial Occlusive Diseases D001157 12 associated lipids
Pain, Postoperative D010149 13 associated lipids
Per page 10 20 50 100 | Total 293

PubChem Associated disorders and diseases

What pathways are associated with Thromboxane b2

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Thromboxane b2?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Thromboxane b2?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Thromboxane b2?

There are no associated biomedical information in the current reference collection.

What genes are associated with Thromboxane b2?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Thromboxane b2?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Thromboxane b2

Download all related citations
Per page 10 20 50 100 | Total 6367
Authors Title Published Journal PubMed Link
Ikemura T et al. KW-4679, an antiallergic drug, inhibits the production of inflammatory lipids in human polymorphonuclear leukocytes and guinea pig eosinophils. 1996 Int. Arch. Allergy Immunol. pmid:8645979
Leung LK and Glauert HP Reduction of the concentrations of prostaglandins E2 and F2alpha, and thromboxane B2 in cultured rat hepatocytes treated with the peroxisome proliferator ciprofibrate. 1996 Toxicol. Lett. pmid:8644126
Saji T et al. [Short- and long-term effects of the new oral prostacyclin analogue, beraprost sodium, in patients with severe pulmonary hypertension]. 1996 J Cardiol pmid:8642506
Thwaites BK et al. Intravenous ketorolac tromethamine worsens platelet function during knee arthroscopy under spinal anesthesia. 1996 Anesth. Analg. pmid:8638787
Garvin PJ et al. Evaluation of the thromboxane A2 synthetase inhibitor OKY-046 in a warm ischemia-reperfusion rat model. 1996 Transplantation pmid:8633364
Suehiro T et al. Thromboxane A2 in preservation-reperfusion injury: the effect of thromboxane A2 synthetase inhibitor. 1996 J. Surg. Res. pmid:8632642
Jacoby RF et al. Chemoprevention of spontaneous intestinal adenomas in the Apc Min mouse model by the nonsteroidal anti-inflammatory drug piroxicam. 1996 Cancer Res. pmid:8631000
McAdam B et al. Transdermal modification of platelet function: an aspirin patch system results in marked suppression of platelet cyclooxygenase. 1996 J. Pharmacol. Exp. Ther. pmid:8627531
Korn RL et al. The effects of Carmeda Bioactive Surface on human blood components during simulated extracorporeal circulation. 1996 J. Thorac. Cardiovasc. Surg. pmid:8622305
Hirashima Y et al. Prevention of cerebrovasospasm following subarachnoid hemorrhage in rabbits by the platelet-activating factor antagonist, E5880. 1996 J. Neurosurg. pmid:8622157
Praticó D and FitzGerald GA Generation of 8-epiprostaglandin F2alpha by human monocytes. Discriminate production by reactive oxygen species and prostaglandin endoperoxide synthase-2. 1996 J. Biol. Chem. pmid:8621535
Awni WM et al. The pharmacokinetic and pharmacodynamic interactions between the 5-lipoxygenase inhibitor zileuton and the cyclo-oxygenase inhibitor naproxen in human volunteers. 1995 Clin Pharmacokinet pmid:8620667
Osterud B et al. Effect of marine oils supplementation on coagulation and cellular activation in whole blood. 1995 Lipids pmid:8614301
Aune B et al. Hormone replacement therapy reduces the reactivity of monocytes and platelets in whole blood--a beneficial effect on atherogenesis and thrombus formation? 1995 Am. J. Obstet. Gynecol. pmid:8610768
Kritz H et al. Isradipine increases vascular prostaglandin I2-formation while the thromboxane B2-synthesis is diminished. 1995 Thromb. Res. pmid:8610276
Cochran JB et al. Age-related mortality and adherent splenic cell mediator production to endotoxin in the rat. 1995 Shock pmid:8608403
Rocca B et al. Increased thromboxane biosynthesis in essential thrombocythemia. 1995 Thromb. Haemost. pmid:8607099
Tarnow P et al. Effects of D-myo-Inositol-1,2,6-triphosphate on eicosanoid formation in burned skin. 1996 J. Surg. Res. pmid:8606494
Huang JZ et al. Study on characteristics of blast-fragment combined injury in dogs. 1996 J Trauma pmid:8606426
Sanderud J et al. D-penicillamine inhibits the action of reactive oxygen species in the pig pulmonary circulation. 1995 J Perinat Med pmid:8606345
Sreedhara R et al. Uremic patients have decreased shear-induced platelet aggregation mediated by decreased availability of glycoprotein IIb-IIIa receptors. 1996 Am. J. Kidney Dis. pmid:8604704
Makheia AN et al. Inhibition of platelet aggregation and thromboxane synthesis by onion and garlic. 1979 Lancet pmid:86023
Jesse RL et al. Dehydroepiandrosterone inhibits human platelet aggregation in vitro and in vivo. 1995 Ann. N. Y. Acad. Sci. pmid:8597466
Berti F et al. Protective effect of furosemide combined with non-steroidal anti-inflammatory drugs administered by inhalation route on guinea-pigs anaphylaxis model. 1995 Arzneimittelforschung pmid:8595068
Murray MJ et al. Select dietary fatty acids attenuate cardiopulmonary dysfunction during acute lung injury in pigs. 1995 Am. J. Physiol. pmid:8594921
Landoni MF and Lees P Pharmacokinetics and pharmacodynamics of ketoprofen enantiomers in calves. 1995 Chirality pmid:8593252
Yokoyama I et al. Beneficial effect of donor pretreatment with thromboxane A2 synthase inhibitor on the graft survival in pig liver transplantation. 1996 J. Surg. Res. pmid:8592420
Zhou W et al. Evidence for altered cellular calcium in the pathogenetic mechanism of acute pancreatitis in rats. 1996 J. Surg. Res. pmid:8592406
Pfister SL and Campbell WB Role of endothelium-derived metabolites of arachidonic acid in enhanced pulmonary artery contractions in female rabbits. 1996 Hypertension pmid:8591886
Pettigrew LC et al. Delayed elevation of platelet activating factor in ischemic hippocampus. 1995 Brain Res. pmid:8590061
Jawerbaum A et al. Hyperglycemia promotes elevated generation of TXA2 in isolated rat uteri. 1995 Prostaglandins pmid:8588071
Myers SI et al. Platelet activating factor (PAF) stimulates release of PGI2 from inflamed rabbit gallbladder cell cultures. 1995 Prostaglandins pmid:8588069
Kane GC et al. Insights into IgE-mediated lung inflammation derived from a study employing a 5-lipoxygenase inhibitor. 1995 Prostaglandins pmid:8588068
Landoni MF et al. Pharmacokinetics and pharmacodynamics of ketoprofen in calves applying PK/PD modelling. 1995 J. Vet. Pharmacol. Ther. pmid:8587147
Cargile JL et al. Effects of tumor necrosis factor blockade on interleukin 6, lactate, thromboxane, and prostacyclin responses in miniature horses given endotoxin. 1995 Am. J. Vet. Res. pmid:8585654
Habib A et al. Increased expression of inducible cyclooxygenase-2 in human endothelial cells by antiphospholipid antibodies. 1995 Thromb. Haemost. pmid:8585020
Davì G et al. Demonstration of Rickettsia Conorii-induced coagulative and platelet activation in vivo in patients with Mediterranean spotted fever. 1995 Thromb. Haemost. pmid:8584998
Friedman M et al. Neutrophil adhesion blockade with NPC 15669 decreases pulmonary injury after total cardiopulmonary bypass. 1996 J. Thorac. Cardiovasc. Surg. pmid:8583821
Hsu LY et al. 2-Heteroaryl 2-substituted phenylketone derivatives and their inhibitory activity on platelet aggregation. 1995 J. Pharm. Pharmacol. pmid:8583390
Panara MR et al. Effects of the novel anti-inflammatory compounds, N-[2-(cyclohexyloxy)-4-nitrophenyl] methanesulphonamide (NS-398) and 5-methanesulphonamido-6-(2,4-difluorothio-phenyl)-1-inda none (L-745,337), on the cyclo-oxygenase activity of human blood prostaglandin endoperoxide synthases. 1995 Br. J. Pharmacol. pmid:8581280
Lu CS et al. [Experimental study on anti-atherosclerotic effect of tongmai jiangzhi oral liquor]. 1995 Zhongguo Zhong Xi Yi Jie He Za Zhi pmid:8580696
Lin Y Vasoactive intestinal polypeptide prevents injury of pulmonary vascular permeability due to xanthine with xanthine oxidase. 1995 Chin. Med. Sci. J. pmid:8580482
Cenni E et al. Platelet and coagulation factor variations induced in vitro by polyethylene terephthalate (Dacron) coated with pyrolytic carbon. 1995 Biomaterials pmid:8580259
Patrono C et al. Characterization of biochemical and functional effects of antiplatelet drugs as a key to their clinical development. 1995 Thromb. Haemost. pmid:8578493
Gold MS et al. Hyperalgesic agents increase a tetrodotoxin-resistant Na+ current in nociceptors. 1996 Proc. Natl. Acad. Sci. U.S.A. pmid:8577723
Somova L Effects of iloprost on salt-sensitive Dahl rats. 1995 Methods Find Exp Clin Pharmacol pmid:8577205
Gil B et al. Effects of marine 2-polyprenyl-1,4-hydroquinones on phospholipase A2 activity and some inflammatory responses. 1995 Eur. J. Pharmacol. pmid:8575515
Kanamori S et al. Effects of dietary fibre on dimethylhydrazine-induced changes in prostanoid concentrations in rat colonic mucosa. 1995 Clin. Exp. Pharmacol. Physiol. pmid:8575110
Lin Y and Sun M [Vasoactive intestinal polypeptide prevents injury of pulmonary vascular permeability due to xanthine with xanthine oxidase]. 1995 Zhongguo Yi Xue Ke Xue Yuan Xue Bao pmid:8575046
Umeda F et al. Prostaglandins and diabetic nephropathy. 1995 Oct-Dec J. Diabetes Complicat. pmid:8573760